The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Perrigo Company PLC

NYSE: PRGO
Last

(U.S.) $86.75

Today's change+1.55 +1.82%
Updated November 21 4:02 PM EST. Delayed by at least 15 minutes.
 

Perrigo Company PLC

NYSE: PRGO
Last

(U.S.) $86.75

Today's change+1.55 +1.82%
Updated November 21 4:02 PM EST. Delayed by at least 15 minutes.

Perrigo Company PLC crosses above 50-day moving average

Perrigo Company PLC closed up sharply Tuesday, rallying (U.S.)$1.55 or 1.82% to (U.S.)$86.75 and crossing above its 50-day moving average. Over the last five days, shares have gained 0.87% and 4.23% year to date. Shares have underperformed the S&P 500 by 21.10% during the last year.

Key company metrics

  • Open(U.S.) $85.60
  • Previous close(U.S.) $85.20
  • High(U.S.) $87.53
  • Low(U.S.) $85.40
  • Bid / Ask(U.S.) $85.25 / (U.S.) $88.00
  • YTD % change+4.23%
  • Volume703,615
  • Average volume (10-day)1,853,300
  • Average volume (1-month)1,425,222
  • Average volume (3-month)1,534,379
  • 52-week range(U.S.) $63.68 to (U.S.) $91.73
  • Beta0.66
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forward17.76×
  • Forward PEG2.47×
  • Indicated annual dividend(U.S.) $0.64
  • Dividend yield0.74%
  • Trailing EPS(U.S.) -$9.14
Updated November 21 4:02 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-26.28%

Perrigo Company PLC has a net profit margin of -26.28%. Besides being negative, it is also below the industry average and implies that this company is not effective at turning revenues into bottom line profit.
Company Books

S&P TSX0.45%Sector:HealthcareIndustry:Pharmaceuticals - Diversified

Latest Company News

View more News
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2017Q2/2017Q1/2017Q4/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201709/30/2017Jul 01, 201707/01/2017Apr 01, 201704/01/2017Dec 31, 201612/31/2016
Revenue1,2311,2381,1941,331
Total other revenue--------
Total revenue1,2311,2381,1941,331
Gross profit498505464488
Total cost of revenue734733730844
Total operating expense1,0691,2241,0661,816
Selling / general / administrative288275282316
Research & development38434042
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)1217551615
Other operating expenses, total-3-2-36--
Operating income16214129-485
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax129-7696-1,644
Income after tax45-7072-1,359
Income tax, total84-724-285
Net income45-7072-1,359
Total adjustments to net income--------
Net income before extra. items45-7072-1,359
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items45-7072-1,359
Inc. avail. to common incl. extra. items45-7072-1,359
Diluted net income45-7072-1,359
Dilution adjustment--00--
Diluted weighted average shares142143144144
Diluted EPS excluding extraordinary itemsvalue per share0.31-0.490.50-9.46
Dividends per sharevalue per share0.160.160.160.15
Diluted normalized EPSvalue per share0.370.310.76-6.68